Left Atrial Appendage Occlusion Study III "LAAOS III"


Phase N/A Results N/A

Summary of Purpose

Atrial fibrillation (AF) is a common heart rhythm disorder that leads to one-sixth of all strokes. Prevention of strokes in AF is achieved through the use of blood thinners such as coumadin. Although these blood thinners are effective, they are limited by the risk of serious bleeding, by physician and patient reluctance to use, and by noncompliance and discontinuation. The left atrial appendage is a structure on...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 September 2016.

1 Jul 2012 20 Mar 2012 1 Nov 2020 1 Nov 2020 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


See All